======= IFI16 ======= == Gene Information == * **Official Symbol**: IFI16 * **Official Name**: interferon gamma inducible protein 16 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3428|3428]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q16666|Q16666]] * **Interactions**: [[https://thebiogrid.org/search.php?search=IFI16&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IFI16|Open PubMed]] * **OMIM**: [[https://omim.org/entry/147586|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the HIN-200 (hematopoietic interferon-inducible nuclear antigens with 200 amino acid repeats) family of cytokines. The encoded protein contains domains involved in DNA binding, transcriptional regulation, and protein-protein interactions. The protein localizes to the nucleoplasm and nucleoli, and interacts with p53 and retinoblastoma-1. It modulates p53 function, and inhibits cell growth in the Ras/Raf signaling pathway. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2011]. * **UniProt Summary**: N/A |PAAD DAPIN| |HIN| |activation of cysteine-type endopeptidase activity| |mononuclear cell differentiation| |monocyte differentiation| |cellular response to interferon-beta| |response to interferon-beta| |intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator| |zymogen activation| |cellular response to glucose starvation| |intrinsic apoptotic signaling pathway by p53 class mediator| |positive regulation of interleukin-1 beta production| |negative regulation of DNA binding| |negative regulation of innate immune response| |negative regulation of viral genome replication| |positive regulation of interleukin-1 production| |cellular response to ionizing radiation| |intrinsic apoptotic signaling pathway in response to DNA damage| |positive regulation of type I interferon production| |regulation of interleukin-1 beta production| |negative regulation of viral life cycle| |negative regulation of cysteine-type endopeptidase activity| |negative regulation of response to biotic stimulus| |regulation of viral genome replication| |regulation of interleukin-1 production| |negative regulation of viral process| |double-stranded DNA binding| |myeloid leukocyte differentiation| |signal transduction by p53 class mediator| |regulation of DNA binding| |regulation of type I interferon production| |regulation of viral life cycle| |intrinsic apoptotic signaling pathway| |negative regulation of immune response| |response to ionizing radiation| |cellular response to starvation| |positive regulation of cysteine-type endopeptidase activity| |protein processing| |negative regulation of binding| |positive regulation of endopeptidase activity| |cellular response to radiation| |defense response to virus| |positive regulation of peptidase activity| |response to starvation| |regulation of viral process| |negative regulation of defense response| |negative regulation of multi-organism process| |regulation of symbiosis, encompassing mutualism through parasitism| |myeloid cell differentiation| |protein maturation| |cellular response to nutrient levels| |regulation of gene expression, epigenetic| |regulation of cysteine-type endopeptidase activity| |negative regulation of endopeptidase activity| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |negative regulation of peptidase activity| |activation of innate immune response| |autophagy| |process utilizing autophagic mechanism| |cellular response to extracellular stimulus| |response to virus| |apoptotic signaling pathway| |cellular response to abiotic stimulus| |cellular response to environmental stimulus| |leukocyte differentiation| |regulation of autophagy| |transcription factor binding| |cellular response to external stimulus| |positive regulation of innate immune response| |negative regulation of proteolysis| |positive regulation of proteolysis| |positive regulation of response to biotic stimulus| |negative regulation of response to external stimulus| |regulation of binding| |nuclear speck| |regulation of endopeptidase activity| |response to radiation| |negative regulation of immune system process| |regulation of peptidase activity| |positive regulation of cytokine production| |regulation of innate immune response| |negative regulation of hydrolase activity| |positive regulation of defense response| |inflammatory response| |response to nutrient levels| |RNA polymerase II proximal promoter sequence-specific DNA binding| |positive regulation of multi-organism process| |regulation of response to biotic stimulus| |response to extracellular stimulus| |cell population proliferation| |hemopoiesis| |positive regulation of response to external stimulus| |hematopoietic or lymphoid organ development| |activation of immune response| |immune system development| |regulation of cytokine production| |regulation of proteolysis| |regulation of defense response| |innate immune response| |positive regulation of hydrolase activity| |regulation of multi-organism process| |cellular response to DNA damage stimulus| |negative regulation of catalytic activity| |regulation of cellular catabolic process| |nucleolus| |negative regulation of transcription by RNA polymerase II| |positive regulation of immune response| |apoptotic process| |defense response to other organism| |regulation of catabolic process| |cellular response to cytokine stimulus| |negative regulation of cellular protein metabolic process| |programmed cell death| |cell death| |immune effector process| |regulation of response to external stimulus| |response to cytokine| |negative regulation of protein metabolic process| |negative regulation of molecular function| |positive regulation of immune system process| |regulation of immune response| |response to abiotic stimulus| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |proteolysis| |regulation of hydrolase activity| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |negative regulation of RNA metabolic process| |defense response| |negative regulation of cellular macromolecule biosynthetic process| |RNA binding| |positive regulation of catalytic activity| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |positive regulation of cellular protein metabolic process| |negative regulation of response to stimulus| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of immune system process| |intracellular signal transduction| |cellular response to stress| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |positive regulation of molecular function| |cellular catabolic process| |immune response| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |membrane| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-2.28| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|-1.93| |[[:results:exp346|CoCl2 18μM R07 exp346]]|-1.79| |[[:results:exp107|UMK57 0.6μM R03 exp107]]|1.75| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|1.89| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18722 * **Expression level (log2 read counts)**: 6.93 {{:chemogenomics:nalm6 dist.png?nolink |}}